Yoshihiro Takai

Prof. Yoshihiro Takai


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2012 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
KTKen Takeda
Ken Takeda
YTYoshihiro Takai
Yoshihiro Takai
KNKakutaro Narazaki
Kakutaro Narazaki
MMMasatoshi Mitsuya
Masatoshi Mitsuya
RURei Umezawa
Rei Umezawa
SYShogo Yamada
Shogo Yamada
Several studies have confirmed the advantages of delivering high doses of external beam radiotherapy to achieve optimal tumor-control outcomes in patients with localized prostate cancer. We evaluated the medium-term treatment outcome after high-dose, image-guided intensity-modulated radiotherapy (IMRT) using intra-prostate fiducial markers for clinically localized prostate cancer. In total, 141 patients with localized prostate cancer treated with image-guided IMRT (76 Gy in 13 patients and 80 Gy in 128 patients) between 2003 and 2008 were enrolled in this study. The patients were classified according to the National Comprehensive Cancer Network-defined risk groups. Thirty-six intermediate-risk patients and 105 high-risk patients were included. Androgen-deprivation therapy was performed in 124 patients (88%) for a median of 11 months (range: 2–88 months). Prostate-specific antigen (PSA) relapse was defined according to the Phoenix-definition (i.e., an absolute nadir plus 2 ng/ml dated at the call). The 5-year actuarial PSA relapse-free survival, the 5-year distant metastasis-free survival, the 5-year cause-specific survival (CSS), the 5-year overall survival (OS) outcomes and the acute and late toxicities were analyzed. The toxicity data were scored according to the Common Terminology Criteria for Adverse Events, version 4.0. The median follow-up was 60 months. The 5-year PSA relapse-free survival rates were 100% for the intermediate-risk patients and 82.2% for the high-risk patients; the 5-year actuarial distant metastasis-free survival rates were 100% and 95% for the intermediate- and high-risk patients, respectively; the 5-year CSS rates were 100% for both patient subsets; and the 5-year OS rates were 100% and 91.7% for the intermediate- and high-risk patients, respectively. The Gleason score (<8 vs. ≥8) was significant for the 5-year PSA relapse-free survival on multivariate analysis (p = 0.044). There was no grade 3 or 4 acute toxicity. The incidence of grade 2 acute gastrointestinal (GI) and genitourinary (GU) toxicities were 1.4% and 8.5%, respectively. The 5-year actuarial likelihood of late grade 2–3 GI and GU toxicities were 6% and 6.3%, respectively. No grade 4 GI or GU late toxicity was observed. These medium-term results demonstrate a good tolerance of high-dose image-guided IMRT. However, further follow-up is needed to confirm the long-term treatment outcomes.

14 May 2014 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
MAMasahiko Aoki
Masahiko Aoki
YTYoshihiro Takai
Yoshihiro Takai
YNYuichiro Narita
Yuichiro Narita
KHKatsumi Hirose
Katsumi Hirose
MSMariko Sato
Mariko Sato
SOShuichi Ono
Shuichi Ono
The purpose of this study was to investigate the relationship between tumor size and blood volume for patients with lung tumors, using dual-energy computed tomography (DECT) and a gemstone spectral imaging (GSI) viewer. During the period from March 2011 to March 2013, 50 patients with 57 medically inoperable lung tumors underwent DECT before stereotactic body radiotherapy (SBRT) of 50–60 Gy in 5–6 fractions. DECT was taken for pretreatment evaluation. The region-of-interest for a given spatial placement of the tumors was set, and averages for CT value, water density and iodine density were compared with tumor size. The average values for iodine density in tumors of ≤2 cm, 2–3 cm, and >3 cm maximum diameter were 24.7, 19.6 and 16.0 (100 µg/cm3), respectively. The average value of the iodine density was significantly lower in larger tumors. No significant correlation was detected between tumor size and average CT value or between tumor size and average water density. Both the average water density and the average CT value were affected by the amount of air in the tumor, but the average iodine density was not affected by air in the tumor. The average water density and the average CT value were significantly correlated, but the average iodine density and the average CT value showed no significant correlation. The blood volume of tumors can be indicated by the average iodine density more accurately than it can by the average CT value. The average iodine density as assessed by DECT might be a non-invasive and quantitative assessment of the radio-resistance ascribable to the hypoxic cell population in a tumor.

1 May 2015 in Medical Physics
Verified
Journal Article
Closed access
XZXiaoyong Zhang
Xiaoyong Zhang
NHNoriyasu Homma
Noriyasu Homma
KIKei Ichiji
Kei Ichiji
YTYoshihiro Takai
Yoshihiro Takai
MYMakoto Yoshizawa
Makoto Yoshizawa

21 December 2012 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
KHKatsumi Hirose
Katsumi Hirose
SMSatoru Monzen
Satoru Monzen
HSHaruka Sato
Haruka Sato
MSMariko Sato
Mariko Sato
MAMasahiko Aoki
Masahiko Aoki
IKIkuo Kashiwakura
Ikuo Kashiwakura
Differentiation-induction therapy is an attractive approach in leukemia treatment. It has been suggested that the accumulation of intracellular reactive oxygen species (ROS) is involved in megakaryocytic differentiation induced by phorbol 12-myristate 13-acetate (PMA) in the K562 leukemia cell line. Therefore, a ROS-inducible technique could be a powerful method of differentiation induction. Accordingly, we hypothesized that ionizing radiation contributes to the acceleration of megakaryocytic differentiation through the accumulation of intracellular ROS in leukemia cells. In the present study, ionizing radiation was shown to promote PMA-induced megakaryocytic differentiation. Cells with high CD41 expression sustained intracellular ROS levels effectively. The enhancement of differentiation by ionizing radiation was found to be regulated through the mitogen-activated protein kinase (MAPK) pathway, involving both extracellular signal-regulated protein kinase 1/2 (ERK1/2) and p38 MAPK. Ionizing radiation also controlled mRNA expression of the oxidative stress response gene heme oxygenase-1 (HO1). Consequently, we concluded that intracellular ROS, increased by ionizing radiation, modulate megakaryocytic differentiation downstream of the MAPK pathway.

5 November 2011 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
RURei Umezawa
Rei Umezawa
HAHisanori Ariga
Hisanori Ariga
YOYoshihiro Ogawa
Yoshihiro Ogawa
KJKeiichi Jingu
Keiichi Jingu
HMHaruo Matsushita
Haruo Matsushita
SYShogo Yamada
Shogo Yamada
To evaluate prognostic factors in salvage radiotherapy (RT) for patients with pre-RT prostate-specific antigen (PSA) < 1.0 ng/ml.

5 November 2015 in Hepatology Research
Verified
Journal Article
Open access
PDF file
AKAkihisa Kakuta
Akihisa Kakuta
KSKoichi Shibutani
Koichi Shibutani
SOShuichi Ono
Shuichi Ono
HMHiroyuki Miura
Hiroyuki Miura
FTFumiyasu Tsushima
Fumiyasu Tsushima
YTYoshihiro Takai
Yoshihiro Takai
Our results indicate that intra-arterial injection can be started at any time after balloon occlusion and that 70 mmHg may be considered as a possible indicator of the end-point for arterial injection.